The status of Nrf2-based therapeutics: current perspectives and future prospects

This mini-review presents the authors' vision on the current status and future trends in the development of neuroprotective agents working via activation of nuclear factor erythroid 2-related factor 2 (Nrf2), and in particular, via disruption of Nrf2-Keap1 interaction. There are two opposite “c...

Full description

Bibliographic Details
Main Authors: Irina G Gazaryan, Bobby Thomas
Format: Article
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Neural Regeneration Research
Online Access:;year=2016;volume=11;issue=11;spage=1708;epage=1711;aulast=Gazaryan